Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Although rituximab therapy improves clinical outcome, some patients develop resistant DLBCL; however, the genetic alterations in these patients are not well documented. To identify the genetic background of refrac...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Park, Ha Young, Lee, Seung-Bok, Yoo, Hae-Yong, Kim, Seok-Jin, Kim, Won-Seog, Kim, Jong-Il, Ko, Young-Hyeh
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349924/
https://ncbi.nlm.nih.gov/pubmed/27835906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13239
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia